Clinical Trials Browser

OTHER × Edema × 90 days × Clear all

NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07443618 2026-03-02

Measuring Fluid Buildup in Cancer Patients

Not yet recruiting

Edema, Lymphedema, Neoplasms

NCT07365618 2026-01-26

LymFit

Phase NA Not yet recruiting

Breast Cancer Lymphedema, Breast Neoplasms, Edema, Motor Activity

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Phase 2 Active not recruiting

71 enrolled 11 charts

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms